Unleashing the potential of DNA and RNA based therapies using AI
Company is active
Event Year: 2022
Company is active
Event Year: 2022
WhiteLab Genomics has pioneered an innovative AI platform designed to expedite the crucial processes of discovery and design within the realm of genomic therapies. Their cutting-edge technology specifically targets the advancement of Cell Therapies, RNA Therapies, and DNA Therapies, offering a significant acceleration in the development of these potentially life-changing treatments. By leveraging the power of artificial intelligence, WhiteLab Genomics aims to unlock the full therapeutic potential of DNA and RNA based approaches, paving the way for more effective and efficient healthcare solutions.
WhiteLab Genomics has pioneered an innovative AI platform designed to expedite the crucial processes of discovery and design within the realm of genomic therapies. Their cutting-edge technology specifically targets the advancement of Cell Therapies, RNA Therapies, and DNA Therapies, offering a significant acceleration in the development of these potentially life-changing treatments. By leveraging the power of artificial intelligence, WhiteLab Genomics aims to unlock the full therapeutic potential of DNA and RNA based approaches, paving the way for more effective and efficient healthcare solutions.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 40
Hiring: No
Team size: 40
Hiring: No
